( March 25, 2024, 8:52 AM EDT) -- WASHINGTON, D.C. — Two former Acclarent Inc. executives convicted of distributing and misbranding medical devices sold in interstate commerce filed a petition for a writ of certiorari with the U.S. Supreme Court asking it to review the First Circuit U.S. Court of Appeals’ decision that affirmed their convictions, arguing that the U.S. Food and Drug Administration’s “intended use” regulations violate their constitutional rights....